| Title: | The association of chronic pain, painkiller use, and potential mediators with liver fat content |
| Journal: | Scientific Reports |
| Published: | 25 Feb 2025 |
| Pubmed: | https://pubmed.ncbi.nlm.nih.gov/39994347/ |
| DOI: | https://doi.org/10.1038/s41598-025-89496-x |
Publication 15907
WARNING: the interactive features of this website use CSS3, which your browser does not support. To use the full features of this website, please update your browser.
Abstract
Excessive accumulation of liver fat content (LFC) is a pathological manifestation of steatotic liver diseases. This study aims to investigate the relationship between chronic pain and LFC development. In the UK Biobank, chronic pain sites were collected via questionnaire, while LFC was measured by magnetic resonance imaging and quantified by Proton Density Fat Fraction (PDFF). During the median follow-up of 10.5 (4.0-17.8) years, in 39,437 individuals, neck/shoulder, back, stomach/abdominal, knee, and general pain achieved significant arithmetic means difference of 0.02, 0.02, 0.04, 0.02, and 0.15 in PDFF (P < 0.05) using multivariable linear regression models. There was a significant dose-effect for number of pain sites and PDFF (P < 0.001). Additionally, the link between pain sites and PDFF was much stronger in aspirin users than non-users, while steroids had the reverse effect (P for interaction < 0.05). C-reactive protein, sleep, diet, and depression were proved to mediated 8.41%, 13.3%, 6.6%, and 23.0% of the relationship, respectively. In conclusion, there were quantified differences in the relationship between chronic pain and LFC. For chronic pain patients with potential liver health issues, aspirin may be prioritized as an analgesic option due to its potential protective benefits, whereas steroid medications should be avoided.</p>
12 Keywords
- Adult
- Aged
- Analgesics
- C-Reactive Protein
- Chronic Pain
- Fatty Liver
- Female
- Humans
- Liver
- Magnetic Resonance Imaging
- Male
- Middle Aged
12 Authors
- Yu Cheng
- Rong Yang
- Yu Jia
- Yiheng Zhou
- Yi Yao
- Can Shen
- Dongze Li
- Rui Zeng
- Zhi Wan
- Qian Zhao
- Lihua Jiang
- Xiaoyang Liao
1 Application
| Application ID | Title |
|---|---|
| 112111 | Multi-system diseases and death trajectory of metabolic dysfunction-associated fatty liver disease |
Enabling scientific discoveries that improve human health